321 related articles for article (PubMed ID: 20930055)
1. Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas.
Christiaans I; Kenter SB; Brink HC; van Os TA; Baas F; van den Munckhof P; Kidd AM; Hulsebos TJ
J Med Genet; 2011 Feb; 48(2):93-7. PubMed ID: 20930055
[TBL] [Abstract][Full Text] [Related]
2. Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri.
van den Munckhof P; Christiaans I; Kenter SB; Baas F; Hulsebos TJ
Neurogenetics; 2012 Feb; 13(1):1-7. PubMed ID: 22038540
[TBL] [Abstract][Full Text] [Related]
3. SMARCB1 mutations are not a common cause of multiple meningiomas.
Hadfield KD; Smith MJ; Trump D; Newman WG; Evans DG
J Med Genet; 2010 Aug; 47(8):567-8. PubMed ID: 20472658
[TBL] [Abstract][Full Text] [Related]
4. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas.
Sestini R; Bacci C; Provenzano A; Genuardi M; Papi L
Hum Mutat; 2008 Feb; 29(2):227-31. PubMed ID: 18072270
[TBL] [Abstract][Full Text] [Related]
5. SMARCB1 involvement in the development of leiomyoma in a patient with schwannomatosis.
Hulsebos TJ; Kenter S; Siebers-Renelt U; Hans V; Wesseling P; Flucke U
Am J Surg Pathol; 2014 Mar; 38(3):421-5. PubMed ID: 24525513
[TBL] [Abstract][Full Text] [Related]
6. Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation.
Bacci C; Sestini R; Provenzano A; Paganini I; Mancini I; Porfirio B; Vivarelli R; Genuardi M; Papi L
Neurogenetics; 2010 Feb; 11(1):73-80. PubMed ID: 19582488
[TBL] [Abstract][Full Text] [Related]
7. Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limb.
Castellanos E; Bielsa I; Carrato C; Rosas I; Solanes A; Hostalot C; Amilibia E; Prades J; Roca-Ribas F; Lázaro C; Blanco I; Serra E;
BMC Med Genomics; 2015 Jan; 8():2. PubMed ID: 25739810
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis.
Hadfield KD; Newman WG; Bowers NL; Wallace A; Bolger C; Colley A; McCann E; Trump D; Prescott T; Evans DG
J Med Genet; 2008 Jun; 45(6):332-9. PubMed ID: 18285426
[TBL] [Abstract][Full Text] [Related]
9. Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas.
Piotrowski A; Xie J; Liu YF; Poplawski AB; Gomes AR; Madanecki P; Fu C; Crowley MR; Crossman DK; Armstrong L; Babovic-Vuksanovic D; Bergner A; Blakeley JO; Blumenthal AL; Daniels MS; Feit H; Gardner K; Hurst S; Kobelka C; Lee C; Nagy R; Rauen KA; Slopis JM; Suwannarat P; Westman JA; Zanko A; Korf BR; Messiaen LM
Nat Genet; 2014 Feb; 46(2):182-7. PubMed ID: 24362817
[TBL] [Abstract][Full Text] [Related]
10. Germline and somatic mutations in meningiomas.
Smith MJ
Cancer Genet; 2015 Apr; 208(4):107-14. PubMed ID: 25857641
[TBL] [Abstract][Full Text] [Related]
11. Germline mutation of INI1/SMARCB1 in familial schwannomatosis.
Hulsebos TJ; Plomp AS; Wolterman RA; Robanus-Maandag EC; Baas F; Wesseling P
Am J Hum Genet; 2007 Apr; 80(4):805-10. PubMed ID: 17357086
[TBL] [Abstract][Full Text] [Related]
12. RNA-based analysis of two SMARCB1 mutations associated with familial schwannomatosis with meningiomas.
Melean G; Velasco A; Hernández-Imaz E; Rodríguez-Álvarez FJ; Martín Y; Valero A; Hernández-Chico C
Neurogenetics; 2012 Aug; 13(3):267-74. PubMed ID: 22752724
[TBL] [Abstract][Full Text] [Related]
13. Whole exome sequencing in a case of sporadic multiple meningioma reveals shared NF2, FAM109B, and TPRXL mutations, together with unique SMARCB1 alterations in a subset of tumor nodules.
Torres-Martín M; Kusak ME; Isla A; Burbano RR; Pinto GR; Melendez B; Castresana JS; Rey JA
Cancer Genet; 2015 Jun; 208(6):327-32. PubMed ID: 25981829
[TBL] [Abstract][Full Text] [Related]
14. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.
Caltabiano R; Magro G; Polizzi A; Praticò AD; Ortensi A; D'Orazi V; Panunzi A; Milone P; Maiolino L; Nicita F; Capone GL; Sestini R; Paganini I; Muglia M; Cavallaro S; Lanzafame S; Papi L; Ruggieri M
Childs Nerv Syst; 2017 Jun; 33(6):933-940. PubMed ID: 28365909
[TBL] [Abstract][Full Text] [Related]
15. Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.
Louvrier C; Pasmant E; Briand-Suleau A; Cohen J; Nitschké P; Nectoux J; Orhant L; Zordan C; Goizet C; Goutagny S; Lallemand D; Vidaud M; Vidaud D; Kalamarides M; Parfait B
Neuro Oncol; 2018 Jun; 20(7):917-929. PubMed ID: 29409008
[TBL] [Abstract][Full Text] [Related]
16. Familial schwannomatosis with a germline mutation of SMARCB1 in Japan.
Asai K; Tani S; Mineharu Y; Tsurusaki Y; Imai Y; Agawa Y; Iwaki K; Matsumoto N; Sakai N
Brain Tumor Pathol; 2015 Jul; 32(3):216-20. PubMed ID: 25631985
[TBL] [Abstract][Full Text] [Related]
17. The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.
Kehrer-Sawatzki H; Farschtschi S; Mautner VF; Cooper DN
Hum Genet; 2017 Feb; 136(2):129-148. PubMed ID: 27921248
[TBL] [Abstract][Full Text] [Related]
18. SMARCB1/INI1 maternal germ line mosaicism in schwannomatosis.
Hulsebos TJ; Kenter SB; Jakobs ME; Baas F; Chong B; Delatycki MB
Clin Genet; 2010 Jan; 77(1):86-91. PubMed ID: 19912265
[TBL] [Abstract][Full Text] [Related]
19. Report of a patient with a constitutional missense mutation in SMARCB1, Coffin-Siris phenotype, and schwannomatosis.
Gossai N; Biegel JA; Messiaen L; Berry SA; Moertel CL
Am J Med Genet A; 2015 Dec; 167A(12):3186-91. PubMed ID: 26364901
[TBL] [Abstract][Full Text] [Related]
20. INI1 mutations in meningiomas at a potential hotspot in exon 9.
Schmitz U; Mueller W; Weber M; Sévenet N; Delattre O; von Deimling A
Br J Cancer; 2001 Jan; 84(2):199-201. PubMed ID: 11161377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
